Updates are available Correction dated 2020-10-22
Click to view Correction: https://doi.org/10.1186/s12894-020-00739-7
-
Authors
Uemura, Hiroji
Koroki, Yosuke http://orcid.org/0000-0003-1461-5869
Iwaki, Yuki
Imanaka, Keiichiro
Kambara, Takeshi
Lopez-Gitlitz, Angela
Smith, Andressa
Uemura, Hirotsugu
-
Funding
Funding for this research was provided by:
Janssen Pharmaceutical K.K., Tokyo, Japan
Janssen Research and Development
- License Information
-
More Information
Article History
Received: 5 May 2020
Accepted: 29 July 2020
First Online: 2 September 2020
Change Date: 22 October 2020
Change Type: Correction
Change Details: An amendment to this paper has been published and can be accessed via the original article.
Ethics approval and consent to participate
: Since this was a retrospective pooled analysis of 3 trials (SPARTAN, TITAN and PCR1008), Institutional Review Board approval to conduct this study was not required.
: Not applicable.
: Dr. Hiroji Uemura received research grants from Janssen Pharmaceutical (during the conduct of the study) and lecture fees/subsidies from Bayer Yakuhin, Limited, Takeda Pharmaceutical Company Limited, AstraZeneca K.K., TAIHO Pharmaceutical Company Limited, Astellas Pharma Inc. and Pfizer Inc.Dr. Takeshi Kambara has no competing interests.Dr. Hirotsugu Uemura received lecture fee from Pfizer Japan Inc., Ono pharmaceutical Co., Ltd., Bayer Yakuhin, Limited, Bristol-Myers Squibb, MSD K.K., research fee or grants from TAIHO Pharmaceutical Company Limited, Janssen Pharmaceutical K.K., Mebix, Inc., MSD K.K., Astellas Pharma Inc., Covence, Bayer Yakuhin, Limited, Prexel International Inc., Pfizer Japan Inc. ICON Japan K.K., Ono pharmaceutical Co., Ltd., Daiichi Ssankyo Company Limited, AstraZeneca K. K, EPS Corporation, Green Peptide, PPD-SNBL K.K., Takeda Pharmaceutical Company Limited, Chugai Pharmaceutical Co. Ltd., IQVIA, Mediscience Planning Inc., Osaka Urology Research Foundation, scholarship/encouragement donations from Asahi Kasei Corporation, Kissei Pharmaceutical Co., Ltd., Novartis Pharmaceutical, Pfizer Japan Inc., Astellas Pharma Inc., Ono pharmaceutical Co., Ltd., Takeda Pharmaceutical Company Limited, Sanofi K.K., Daiichi Sankyo Co., Ltd.The following authors are full-time employees of Janssen Pharmaceutical K.K. of Johnson & Johnson: Yosuke Koroki, Yuki Iwaki, and Keiichiro Imanaka; and Janssen Research and Development: Andressa Smith and Angela Lopez-Gitlitz.
